insulin glp 1 combo GLP-1 Agonists: Increasing Effective Release FIGURE 4. The American Diabetes

The progression of NASH is closely related to the degree of liver fibrosis

Learn more about Squalane This ingredient is a blend of long-chain fatty alcohols (myristyl, cetyl, stearyl, arachidyl, and behenyl)

Trends in discontinuation by indication Side effects were consistently the top reason for stopping treatment for patients receiving ADM and AOM GLP-1s

Some patients find relief with digestive enzymes taken with meals, particularly those containing alpha-galactosidase (Beano) for carbohydrate digestion, though these have limited evidence and are not FDA-approved specifically for GLP-1 side effects

Common triggers include: Large meals High-fat or fried foods Eating too quickly Drinking large volumes with meals Lying down soon after eating Dietitian POV: Who GLP-1s Are (and Arent) For GLP-1s May Be Supportive For: Individuals with insulin resistance or type 2 diabetes Those with obesity who have not responded to lifestyle changes alone Patients with strong medical oversight and nutrition support GLP1s- May Not Be Ideal For: Individuals with uncontrolled GERD or severe reflux history Those with gastroparesis or significant GI motility disorders Anyone unwilling or unable to adjust eating patterns Dietitian Note: GLP-1 success is not just about appetite suppressionits about learning how to eat differently